Ariana’s KEM® Artificial Intelligence platform enables to fast track Drug Development implementing patient stratification for precision medicine. KEM® is an FDA-tested clinical data analysis system that enables full exploitation of complex datasets. It has uniquely demonstrated its ability to extract biomarkers from small sets of patients.
